North America Patient Care Monitoring Device Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Desk Research

Desk work was used to set the market perimeter and to build clean input series that can be audited later. We relied on public and official sources, including the FDA device databases and safety communications, the US Centers for Disease Control and Prevention for health burden signals, the US Census Bureau for demographic baselines, and OECD health statistics for cross-country comparability.

To ensure inputs matched how devices are bought and deployed, we also reviewed sources such as hospital and health system procurement disclosures, company annual filings and investor decks, medical association publications, and reputable coverage of approvals and product launches. In a few places, we used paid subscriptions for company financials and patent databases to confirm product activity and sanity check growth patterns. These examples are not exhaustive, and we reviewed many other public sources for data collection, validation, and clarification.

Primary Interviews and Surveys

Primary work focused on validating device scope and how pricing logic maps to actual purchase decisions, and then pressure testing demand signals such as monitoring intensity in acute care and adoption in home and post-acute settings. We spoke with a mix of device makers, distributors, clinical users, and procurement roles across the United States, Canada, and Mexico. This input helped close gaps left by public datasets and supported assumption checks before finalizing the model.

Distribution of primary research fieldwork respondents

Sizing started with a top-down rebuild of addressable demand, where healthcare delivery activity and patient monitoring intensity were translated into device demand by care setting and monitoring category, then converted into revenue using typical ASP ranges. Once that structure was in place, we corroborated totals with selective bottom-up checks, including sampled product revenue rollups from public financials, channel feedback on unit movement, and spot checks of ASP movement in tenders and procurement notes.

The model was anchored on a practical set of inputs that can be traced and updated, including hospital admissions and procedure volumes that drive monitoring needs, chronic disease and aging population trends that lift longer term monitoring usage, care shifting toward home and post-acute settings, replacement cycles for monitoring equipment, and price mix changes as multi-parameter monitoring expands. For the forecast, scenario analysis was applied around adoption speed and pricing mix, and then reviewed with expert views so the final curve reflects observed buying behavior rather than a single aggressive case. Where bottom-up signals were incomplete for smaller categories, we filled gaps using penetration and replacement assumptions validated through interviews, and then rechecked against the total demand pool.

Outputs were triangulated against independent signals such as procurement activity, public revenue disclosures, and major regulatory and product-launch timing, followed by variance checks to catch outliers by country and care setting. If a number moved too far from the supporting indicators, we rechecked inputs, revisited pricing assumptions, and, in some cases, re-contacted sources to confirm whether the change was real or driven by model structure.

Before sign-off, the work is reviewed in multiple steps so that assumptions, units, and conversions remain consistent across the time series. Reports are refreshed annually, and interim updates are made when material events can shift demand or pricing, including reimbursement changes or major device recalls. Immediately before delivery, a final pass is completed so clients receive the latest updated view.

Published market sizes for patient care monitoring devices can differ even when the topic sounds identical, because teams do not always count the same device scope, geography, or revenue types. Differences also show up in how pricing is carried forward, which demand signals are used to project adoption, and how recently the assumptions were refreshed.

A common gap is that some estimates expand the market into monitoring services or broader digital health system revenues, and that can lift totals quickly. In Mordor Intelligence modeling, only device revenues tied to patient care monitoring are counted, while consumer wellness wearables and service line items are kept out, which keeps the value closer to an auditable device demand pool.

Benchmark comparison

Taken together, the spread is mainly explained by what is counted as market revenue and how pricing and adoption are carried across settings like acute care and home care. By keeping inputs tied to observable care activity, replacement behavior, and realistic ASP bands, the sizing steps stay repeatable and easier to validate during updates.